Terms: = Prostate cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
42 results:
1. Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway.
Sun D; Guo J; Liang W; Chen Y; Wei S; Li A; Wang L; Chen X
Med Oncol; 2024 Jan; 41(2):44. PubMed ID: 38170382
[TBL] [Abstract] [Full Text] [Related]
2. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract] [Full Text] [Related]
3. foxo3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell.
Tao Y; Liu S; Lu J; Fu S; Li L; Zhang J; Wang Z; Hong M
BMC Urol; 2022 Apr; 22(1):70. PubMed ID: 35488328
[TBL] [Abstract] [Full Text] [Related]
4. foxo3a and Its Regulators in prostate cancer.
Habrowska-Górczyńska DE; Kozieł MJ; Kowalska K; Piastowska-Ciesielska AW
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830408
[TBL] [Abstract] [Full Text] [Related]
5. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
[TBL] [Abstract] [Full Text] [Related]
6. MiR-223-3p targets foxo3a to inhibit radiosensitivity in prostate cancer by activating glycolysis.
Zhou K; Wei Y; Li X; Yang X
Life Sci; 2021 Oct; 282():119798. PubMed ID: 34237309
[TBL] [Abstract] [Full Text] [Related]
7. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
8. Circulating IGF-1 promotes prostate adenocarcinoma via foxo3A/BIM signaling in a double-transgenic mouse model.
Wang S; Wang N; Yu B; Cao M; Wang Y; Guo Y; Zhang Y; Zhang P; Yu X; Wang S; Zeng L; Liang B; Li X; Wu Y
Oncogene; 2019 Sep; 38(36):6338-6353. PubMed ID: 31312023
[TBL] [Abstract] [Full Text] [Related]
9. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor foxo3.
Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
[TBL] [Abstract] [Full Text] [Related]
10. Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.
Alwhaibi A; Verma A; Artham S; Adil MS; Somanath PR
Biochem Pharmacol; 2019 Oct; 168():1-13. PubMed ID: 31202735
[TBL] [Abstract] [Full Text] [Related]
11. Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors.
Lynch JT; Polanska UM; Hancox U; Delpuech O; Maynard J; Trigwell C; Eberlein C; Lenaghan C; Polanski R; Avivar-Valderas A; Cumberbatch M; Klinowska T; Critchlow SE; Cruzalegui F; Barry ST
Mol Cancer Ther; 2018 Nov; 17(11):2309-2319. PubMed ID: 30097489
[TBL] [Abstract] [Full Text] [Related]
12. Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest.
Oak C; Khalifa AO; Isali I; Bhaskaran N; Walker E; Shukla S
Int J Oncol; 2018 Aug; 53(2):835-843. PubMed ID: 29767250
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting foxo3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract] [Full Text] [Related]
14. Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition.
Damrauer JS; Phelps SN; Amuchastegui K; Lupo R; Mabe NW; Walens A; Kroger BR; Alvarez JV
Mol Cancer Res; 2018 Apr; 16(4):599-609. PubMed ID: 29330285
[TBL] [Abstract] [Full Text] [Related]
15. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in prostate cancer Cell Lines via the Akt/foxo3a Signaling Pathway.
Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
[TBL] [Abstract] [Full Text] [Related]
16. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
[TBL] [Abstract] [Full Text] [Related]
17. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-foxo3a pathway.
Liu W; Wang X; Liu Z; Wang Y; Yin B; Yu P; Duan X; Liao Z; Chen Y; Liu C; Li X; Dai Y; Tao Z
Br J Cancer; 2017 Oct; 117(8):1139-1153. PubMed ID: 29017179
[TBL] [Abstract] [Full Text] [Related]
18. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote prostate Tumorigenesis and Cell Invasion.
Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
[TBL] [Abstract] [Full Text] [Related]
19. Withaferin A Inhibits prostate Carcinogenesis in a PTEN-deficient Mouse Model of prostate cancer.
Moselhy J; Suman S; Alghamdi M; Chandarasekharan B; Das TP; Houda A; Ankem M; Damodaran C
Neoplasia; 2017 Jun; 19(6):451-459. PubMed ID: 28494348
[TBL] [Abstract] [Full Text] [Related]
20. foxo3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in prostate cancer.
Imada K; Shiota M; Kuroiwa K; Sugimoto M; Abe T; Kohashi K; Yokomizo A; Eto M; Naito S; Oda Y
Prostate; 2017 Feb; 77(2):145-153. PubMed ID: 27699813
[TBL] [Abstract] [Full Text] [Related]
[Next]
